However, TCGA database (Figure 1b) analysis exhibits alterations in NUAK2 expression, comprising mostly amplifications in reproductive organ tumors, such as breast, ovarian, and uterine, in addition to other tumor types, including melanoma, liver, and lung cancers [37]. This evidence concerns the gene NUAK2 and melanoma.